Reuters logo
BRIEF-Jazz pharmaceuticals announces Q1 2017 financial results
2017年5月9日 / 晚上8点29分 / 5 个月前

BRIEF-Jazz pharmaceuticals announces Q1 2017 financial results

May 9 (Reuters) - Jazz Pharmaceuticals PLC:

* Jazz pharmaceuticals announces first quarter 2017 financial results

* Q1 adjusted earnings per share $2.31

* Q1 GAAP earnings per share $1.41

* Q1 revenue $376 million versus I/B/E/S view $377 million

* Q1 earnings per share view $2.34 -- Thomson Reuters I/B/E/S

* Sees 2017 total net product sales $1,617 million to $1,692 million

* Sees 2017 GAAP net income per diluted share $6.55-$7.55

* Sees 2017 non-gaap adjusted net income per diluted share $10.70-$11.30

* FY2017 earnings per share view $11.12, revenue view $1.67 billion -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below